Immune Thrombocytopenia: NVG-2089 Treatment Study

We are testing a new intravenous treatment, NVG-2089, for individuals with Immune Thrombocytopenia. The study aims to evaluate its safety and how well it works in increasing platelet counts.

Efficacy phase (II)No Placebo Cost Reimbursement Investigational Medicines InjectionHematology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Human Normal Immunoglobulin Pharma Plasma

Human Normal Immunoglobulin Pharma Plasma is a medicine made from donated blood that provides antibodies to help prevent or treat immune system problems.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Human Normal Immunoglobulin

Human normal immunoglobulin is a preparation of antibodies from healthy donors used to boost immune protection and treat certain immune-related disorders.

Human Normal Immunoglobulin (Iv)

Human normal immunoglobulin (IV) is a substance made from donated antibodies given intravenously to boost or regulate immune function.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Nvg-2089

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Beriglobin

Beriglobin P

Beriglobina P

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Geniko Nosokomeio Thessalonikis George Papanikolaou

Hematology Clinic

Asvestochóri, Greece

Olympion Therapeftirio General Clinic Of Patras S.A.

Hematology Department

Pátra, Greece

Ippokratio General Hospital Of Thessaloniki

2nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki

Thessaloníki, Greece

Sponsor: Nuvig Therapeutics Inc.

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.